Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The new assay can help develop products for hair re-growth.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Minoxidil, when used with a diuretic and β-blocking agent, can safely lower blood pressure in most children with severe hypertension due to kidney disease, with minimal side effects.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Targeting neurosteroids may help prevent drug relapse.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Minoxidil can reduce functions related to androgen receptors.

Anti-androgens might help reduce COVID-19 severity in men.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Low-dose spironolactone can be effective for treating hair loss in women.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Spironolactone may cause increased brain pressure in some patients.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Dutasteride reduces DHT more effectively than finasteride.

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.